Author:
Gordon Paul,Emerson Hannah M.,Dickerson Faith,Patel Surbhi B.,Riebe Genevieve
Publisher
Springer International Publishing
Reference79 articles.
1. Viswanathan M, Hartmann K, McKoy N, Stuart G, Rankins N, Thieda P, et al. Management of uterine fibroids: an update of the evidence. Evid Rep Technol Assess. 2007;154:1–122.
2. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–7.
3. Wise LA, Palmer JR, Spiegelman D, Harlow BL, Stewart EA, Adams-Campbell LL, et al. Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology. 2005;16(3):346–54.
4. Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG Int J Obstet Gy. 2017;124(10):1501–12.
5. Food US, Administration D. FDA updated assessment of the use of laparoscopic power morcellators to treat uterine fibroids. FDA safety communication. USFDA: Silver Spring; 2017.